Cargando…
Castleman's disease with TAFRO syndrome: a case report from Syria
Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We pres...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451894/ https://www.ncbi.nlm.nih.gov/pubmed/28580156 http://dx.doi.org/10.1093/omcr/omx021 |
_version_ | 1783240269402996736 |
---|---|
author | Alhoulaiby, Sami Ahmad, Basel Alrstom, Ali Kudsi, Mayssoun |
author_facet | Alhoulaiby, Sami Ahmad, Basel Alrstom, Ali Kudsi, Mayssoun |
author_sort | Alhoulaiby, Sami |
collection | PubMed |
description | Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We present the first case of TAFRO syndrome in Syria. A 58-year-old Caucasian male with no relevant history presented with fatigue, oliguria, decreased platelets, increased creatinine level, hepatosplenomegaly, ascites, pitting edema and lymph node enlargement. Possible differential diagnoses were excluded by laboratory, radiologic and cytologic tests including TB, malignancy and autoimmune diseases. A biopsy of a supraclavicular lymph node confirmed Castleman disease. Our patient had Catleman's disease, and presented with only four diagnostic criteria for TAFRO syndrome (Myelofibrosis was absent) in addition to other minor characteristics (microcytic anemia, negative HIV and HHV-8 infections.) which make the presentation consistent with TAFRO syndrome described in the Japanese cases. The criteria for diagnosing TAFRO syndrome are still changing, and the pathophysiology behind it is unclear. We recommend further research to understand this syndrome taking into account that its prevalence might be worldwide. |
format | Online Article Text |
id | pubmed-5451894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54518942017-06-02 Castleman's disease with TAFRO syndrome: a case report from Syria Alhoulaiby, Sami Ahmad, Basel Alrstom, Ali Kudsi, Mayssoun Oxf Med Case Reports Case Report Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We present the first case of TAFRO syndrome in Syria. A 58-year-old Caucasian male with no relevant history presented with fatigue, oliguria, decreased platelets, increased creatinine level, hepatosplenomegaly, ascites, pitting edema and lymph node enlargement. Possible differential diagnoses were excluded by laboratory, radiologic and cytologic tests including TB, malignancy and autoimmune diseases. A biopsy of a supraclavicular lymph node confirmed Castleman disease. Our patient had Catleman's disease, and presented with only four diagnostic criteria for TAFRO syndrome (Myelofibrosis was absent) in addition to other minor characteristics (microcytic anemia, negative HIV and HHV-8 infections.) which make the presentation consistent with TAFRO syndrome described in the Japanese cases. The criteria for diagnosing TAFRO syndrome are still changing, and the pathophysiology behind it is unclear. We recommend further research to understand this syndrome taking into account that its prevalence might be worldwide. Oxford University Press 2017-06-01 /pmc/articles/PMC5451894/ /pubmed/28580156 http://dx.doi.org/10.1093/omcr/omx021 Text en © The Author 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Alhoulaiby, Sami Ahmad, Basel Alrstom, Ali Kudsi, Mayssoun Castleman's disease with TAFRO syndrome: a case report from Syria |
title | Castleman's disease with TAFRO syndrome: a case report from Syria |
title_full | Castleman's disease with TAFRO syndrome: a case report from Syria |
title_fullStr | Castleman's disease with TAFRO syndrome: a case report from Syria |
title_full_unstemmed | Castleman's disease with TAFRO syndrome: a case report from Syria |
title_short | Castleman's disease with TAFRO syndrome: a case report from Syria |
title_sort | castleman's disease with tafro syndrome: a case report from syria |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451894/ https://www.ncbi.nlm.nih.gov/pubmed/28580156 http://dx.doi.org/10.1093/omcr/omx021 |
work_keys_str_mv | AT alhoulaibysami castlemansdiseasewithtafrosyndromeacasereportfromsyria AT ahmadbasel castlemansdiseasewithtafrosyndromeacasereportfromsyria AT alrstomali castlemansdiseasewithtafrosyndromeacasereportfromsyria AT kudsimayssoun castlemansdiseasewithtafrosyndromeacasereportfromsyria |